alexa Anti-viral Immunity And Measures To Control Disease Pathogenesisin The Hematopoietic Stem Cell Transplant Setting
ISSN: 1948-5964

Journal of Antivirals & Antiretrovirals
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th World Congress on Virology
October 06-08, 2014 Hilton San Antonio Airport, TX, USA

Ashok Srinivasan
ScientificTracks Abstracts: J Antivir Antiretrovir
DOI: 10.4172/1948-5964.S1.020
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative modality for children with certain hematologic malignancies and non-malignant disorders. Viral infections post-transplant contribute significantly to the morbidity and mortality from this procedure.Serious viral infections are fatal in 15-20% of cases. Cytomegalovirus (CMV), adenovirus (ADV), Epstein-Barr virus (EBV), respiratory viruses, human herpes viruses, and BK virus account for the majority of viral infections. Screening for CMV and ADV viremia, and pre-emptive therapy has significantly reduced the incidence of CMV and ADV disease. Newer drugs for adenovirus such as brincidofovirmay be less toxic,andmore efficacious compared to cidofovir. EBVspecific cytotoxic T-lymphocytes are an attractive adjunct to monoclonal anti-B-cell antibody therapy. Therapeutic option forparainfluenza virus with a drug cleaving the sialic acid viral receptor on respiratory epithelial cells is in a clinical trial. Manipulation of the graft withselective depletion of na?ve T-cells to prevent graft-versus-host disease (GVHD), and infusion of NK cells post-transplant may allow for early immune reconstitution and improved anti-viral immunity in the haplo-identical transplant setting. However T-cell depletion is associated with increased relapse. An alternative to ex-vivo T-cell depletion is to administer donor T-cells that incorporate a suicide gene that can be activated in the event of GVHD. Treatment with allogeneic virus-specific cytotoxic T-lymphocytes can effectively reconstitute antiviral immunity against CMV, EBV and ADV. Newer antiviral drugs and cellular therapy promise an exciting future to control viral disease in the HSCT setting.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version